Clinical Trials in Pittsburgh

Showing 7141-7160 of 16,007 trials

A Study of Modified Stem Cells in Stable Ischemic Stroke

NCT01287936

The primary purpose of the clinical study is to determine the safety of a modified stem cell SB623 when administered to chronic, stable ischemic stroke patients. A second purpose is to determine whether SB623 might improve stroke symptoms. Chronic, stable ischemic stroke patients must be between 6 and 60 months after their stroke, and with only this one prior stroke, and with no further improvement from physical therapy.

Chronic Ischemic Stroke

SanBio, Inc.18 participantsStarted Jan 2011

Birmingham, Alabama, United States • Stanford, California, United States • Atlanta, Georgia, United States +2 more locations

UNKNOWNNA< 1 mile

Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

NCT05274230

The purpose of this research is to examine a wearable device called Apollo that emits gentle vibrations found to benefit mood, energy, and focus. We want to understand how it affects outcomes related to MDMA-assisted psychotherapy for PTSD including depression, anxiety and emotion regulation. This study will test whether regular use of the Apollo wearable improves rates of sustained symptom remission in PTSD following MDMA-assisted psychotherapy over the course of two years

Stress Disorders, Post-Traumatic

Apollo Neuroscience, Inc.200 participantsStarted Dec 2021

Pittsburgh, Pennsylvania, United States

A Study of Modified Stem Cells in Stable Ischemic Stroke

Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

Find Trials by Condition in Pittsburgh

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Sargramostim Use in COVID-19 to Recover Patient Health

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Enhancing Care of the Aged and Dying in Prisons Ph II

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Androgen Reduction in Congenital Adrenal Hyperplasia

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Peripheral Nerve Stimulation Therapy for Atrial Fibrillation

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis